Open AccessThe price of shortening anti–hepatitis C virus therapy: Is this truly cost saving?
Author(s) -
Younossi Zobair M.
Publication year - 2015
Publication title -
clinical liver disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 14
ISSN - 2046-2484
DOI - 10.1002/cld.514
Subject(s) - ribavirin , medicine , pegylated interferon , cirrhosis , hepatitis c , hepatitis c virus , viral load , intensive care medicine , virus , immunology
Watch a video presentation of this article Watch the interview with the author